US Patent 11179395 Treating melanoma with mebendazole and a mitogen-activated kinase inhibitor

Patent 11179395 was granted and assigned to Georgetown University on November, 2021 by the United States Patent and Trademark Office.

Is a

Patent Applicant

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

November 23, 2021

Patent Application Number

15923244

Date Filed

March 16, 2018

Patent Primary Examiner

Patent abstract

Provided herein are methods for treating melanoma in a subject.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 11179395 Treating melanoma with mebendazole and a mitogen-activated kinase inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.